Drugs

What to do with Rituximab intolerant patients? – Timothy Voorhees

Photo from Timothy Voorhees/Twitter

Jul 28, 2023, 20:23

What to do with Rituximab intolerant patients? – Timothy Voorhees

What to do with Rituximab intolerant patients? Don’t drop CD20 Ab therapy, switch to Obinutuzumab instead! Check out our letter below.

For article: Click here
Source: Timothy Voorhees/Twitter

cancer lymphoma Obinutuzumab OncoDaily Oncology Pharma Rituximab Timothy Voorhees

Aladina Foundation was Honored with the Yvonne Humanitarian Award by OncoDaily

Rod Stewart and Prostate Cancer: How He Went Against, How He Survived, and More

Celebrating the Holiday Magic with Medical Community

Melanie Griffith and Skin Cancer: How She Went Against, How She Survived, and More

2024 ASCO Election Results

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Blog

Dec 28, 2024, 16:31

Patela Care Foundation: Celebrating this season and forging treasured memories with the triumphant pediatric champions

Blog

Dec 28, 2024, 16:28

Brett Wilson: Be the LIGHT OF HOPE for Walking Miracles This Year in West Virginia and Pittsburgh

Blog

Dec 28, 2024, 16:23

Sarah Cannon Transplant and Cellular Therapy Network is hiring

Career

Dec 28, 2024, 16:17

Brian Vesall Received the Jordan Jones Memorial Achievement Award for Advocacy and Leadership

Science

Dec 28, 2024, 16:08

Jonathan Govette: AI in Healthcare: Bridging the Gap Between Potential and Adoption

Career

Dec 28, 2024, 16:06

Join the CCI Europe team as a Junior Projects Coordinator in Vienna

Science

Dec 28, 2024, 15:55

Chris Boerner: The FDA approved our new subcutaneous immunotherapy treatment

Science

Dec 28, 2024, 15:46

Vivek Subbiah: Our paper on the development of PROTAC degraders of oncogenic RET protein

Drugs

Dec 28, 2024, 15:46

Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC

Blog

Dec 28, 2024, 15:14

Can clinical trials transform cancer care? - UICC

Blog

Dec 28, 2024, 14:29

Matthias Dietzel: What is the impact of prostate imaging quality?

Blog

Dec 28, 2024, 14:25

The IASLC’s Hot Topic in Basic and Translational Science: SCLC has extended the abstract submission deadline